JBC INTERFERin siRNA transfection reagent

HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Lopez-Ilasaca, M.
Right arrow Articles by Wetzker, R.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Lopez-Ilasaca, M.
Right arrow Articles by Wetzker, R.

J Biol Chem, Vol. 273, Issue 5, 2505-2508, January 30, 1998

COMMUNICATION
Phosphoinositide 3-Kinase gamma  Is a Mediator of Gbeta gamma -dependent Jun Kinase Activation*

Marco Lopez-Ilasaca, J. Silvio GutkindDagger , and Reinhard Wetzker§

From the Max Planck Research Unit "Molecular Cell Biology," Medical Faculty, University of Jena, 07747 Jena, Germany and the Dagger  Molecular Signaling Unit, Laboratory of Cellular Development and Oncology, NIDR, National Institutes of Health, Bethesda, Maryland 20892

    ABSTRACT
Top
Abstract
Introduction
Procedures
Results & Discussion
References

Jun kinases (JNK) are involved in the stress response of mammalian cells. Stimulation of JNK can be induced by stress factors and by agonists of tyrosine kinase and G protein-coupled receptors. G protein-dependent receptors stimulate JNK via Gbeta gamma subunits of heterotrimeric G proteins, but the subsequent signaling reaction has been undefined. Here we demonstrate JNK activation in COS-7 cells by Gbeta gamma -stimulated phosphoinositide 3-kinase gamma  (PI3Kgamma ). Signal transduction from PI3Kgamma to JNK can be suppressed by dominant negative mutants of Ras, Rac, and the protein kinase PAK. These results identify PI3Kgamma as a mediator of Gbeta gamma -dependent regulation of JNK activity.

    INTRODUCTION
Top
Abstract
Introduction
Procedures
Results & Discussion
References

Interaction of cells with a wide variety of agonists results in a stimulation of intracellular mitogen-activated protein kinase (MAPK)1 cascades. MAPKs control the expression of genes that are important for the regulation of many cell functions including proliferation and differentiation. In mammalian cells three parallel MAPK pathways have been characterized so far (1). The canonical MAPK cascade composed of Raf, MEK, and ERK is regulated by the Ras GTPase in response to agonists of tyrosine kinase and G protein-coupled receptors. ERK species catalyze the phosphorylation of transcription factors including Elk-1, thus controlling the expression of several genes (2).

A second MAPK cascade that is stimulated by osmotic stress regulates the activity of the protein kinase p38. Signal transduction to p38 and the function of this pathway are still unclear. Like p38 the elements of the Jun kinase (JNK) cascade as a third MAPK pathway are involved in the stress response of mammalian cells. JNK can be stimulated by stress factors like interleukin 1 and tumor necrosis factor but also by agonists of tyrosine kinase and G protein-coupled receptors (3, 4). Available evidences point to an involvement of the small GTPase Rac and several protein kinases in the regulation of JNK activity (5). In some cellular systems the STE 20 homologue PAK was found to act as a JNK kinase kinase kinase (6). PAK is able to activate JNK via sequential stimulation of the protein kinases MEKK and SEK.

The mechanism of signal transduction from G protein-coupled receptors to the JNK cascade is only partially understood. Using COS-7 cells as a transient expression system a recent report showed the involvement of Gbeta gamma subunits of heterotrimeric G proteins in the stimulation of JNK by agonists of the G protein-coupled muscarinergic receptor m2 (7). Additionally the small GTPases Ras and Rac have been demonstrated to mediate signal transduction from G protein-coupled receptor to JNK, but the topology of the signaling path from Gbeta gamma to Ras and Rac remains unknown (7-9).

One candidate for the link of G protein-coupled receptor and JNK cascade is phosphoinositide 3-kinase gamma  (PI3Kgamma ). This subspecies of the PI3K family is stimulated in vitro by Gbeta gamma and recently has been shown to be involved in signal transduction from G protein-coupled receptor to the ERK path of MAPK cascades (10). We now present evidences that JNK stimulation by an agonist of the m2 muscarinergic receptor and by Gbeta gamma also implies a PI3K. Overexpression of PI3Kgamma in COS-7 cells induces a significant increase of JNK activity. Stimulation of JNK by Gbeta gamma can be suppressed by the PI3K inhibitor wortmannin and a lipid kinase negative mutant of PI3K. Dominant negative mutants of Ras, Rac, and PAK significantly reduce the stimulatory effect of PI3Kgamma on JNK. Thus PI3Kgamma seems to act as an intermediate connecting G protein-coupled receptors to the JNK cascade.

    EXPERIMENTAL PROCEDURES
Top
Abstract
Introduction
Procedures
Results & Discussion
References

Cell Culture and Transfection-- COS-7 cells (ATCC) were cultured in Dulbecco's modified Eagle's medium supplemented with 10% fetal bovine serum. Cells were split the day before transfection. Subconfluent cells were transfected with pcDNAIII-HA-JNK or pcDNAIII-HA-MAPK and additional DNAs, following the DEAE-dextran technique, adjusting the total amount of DNA to 5 µg per plate with vector DNA when necessary. Assays were performed 48 h after transfection (9). For JNK assays the cells were serum-starved for 2 h, whereas for MAPK the cells were starved overnight in serum-free medium.

DNA Constructs-- Expression plasmids for an epitope-tagged JNK and MAPK, pcDNA3 HA-JNK and pcDNA3 MAPK, respectively, as well as expression plasmids for the dominant negative mutants of the small GTP-binding proteins Ras, RhoA, Rac1, and Cdc42 have been described (9, 11). PI3Kgamma and dominant negative PI3Kgamma were used as described previously (10). pcDNA3-p101 was kindly provided by Dr. Len Stephens and prepared as published recently (12). An expression plasmid for the N-terminal 150-amino acid noncatalytic domain of Pak1, which contains the Rac/Cdc42 binding region, was cloned into pcDNA3 vector coding the NH2-terminal myristoylation membrane localization signal from c-Src (13, 14). The final construct was designated pcDNA3-myr-PAK(N). Efficacy of dominant negative mutants of PI3Kgamma , Ras, RhoA, Rac1, Cdc42, and PAK to suppress muscarinergic response in COS-7 cells has been established recently (7, 10, 14).

Kinase Assays-- JNK assays in cells transfected with an epitope-tagged JNK construct (HA-JNK) was determined as described previously (9) using purified, bacterially expressed GST-ATF2(96) fusion protein as a substrate. Briefly, serum-starved cells left untreated or stimulated with various agents were lysed, and after centrifugation, clarified supernatants were immunoprecipitated with an anti-hemagglutinin monoclonal antibody 12CA5 (Babco, Richmond, CA) for 1-2 h at 4 °C, and immunocomplexes were recovered with the aid of GammaBind (Pharmacia, Uppsala). Pellets were then washed three times with phosphate-buffered saline solution, supplemented with 1% Nonidet P-40, and 2 mM sodium vanadate, once with 0.5 M LiCl in 100 mM Tris, pH 7.5, and once with kinase reaction buffer (12.5 mM MOPS, pH 7.5, 12.5 mM beta -glycerophosphate, 7.5 mM MgCl2, 0.5 mM EGTA, 0.5 mM sodium fluoride, 0.5 mM vanadate). Reactions were performed in a 30-µl volume of kinase reaction buffer containing 1 µCi of [gamma -32P]ATP/reaction, 20 µM unlabeled ATP, and 1.5 mg/ml substrate at 30 °C for 30 min. Reactions were terminated by addition of 5× Laemmli buffer, boiled, and electrophoresed in 12% polyacrylamide gel. Phosphorylated GST-ATF2(96) was visualized by autoradiography and quantified with a PhosphorImager. MAPK activity in cells transfected with an epitope-tagged MAPK (HA-MAPK) was determined as described previously (11). In each case, parallel samples were immunoprecipitated with anti-HA antibody and processed by Western blot analysis using the appropriate antibody (Santa Cruz Technology, Santa Cruz, CA). Immunocomplexes were visualized by enhanced chemiluminescence detection (Amersham) with the use of goat antiserum to rabbit or mouse immunoglobulin G coupled to horseradish peroxidase (Santa Cruz Technology).

    RESULTS AND DISCUSSION
Top
Abstract
Introduction
Procedures
Results & Discussion
References

To investigate signaling from G protein-coupled receptor to JNK the muscarinergic m2 receptor has been transiently expressed in COS-7 cells. Confirming previous results (7) we observed an increase of JNK activity after treatment with the receptor agonist carbachol (Fig. 1A). Overexpression of Gbeta gamma mimics the effect of carbachol on JNK. As shown in Fig. 1A both m2- and Gbeta gamma -mediated stimulation could be effectively suppressed by wortmannin, a specific inhibitor of PI3K. In contrast JNK activation by the stress-inducing agent anisomycin was unaffected by wortmannin, demonstrating the specificity of this approach. Another PI3K inhibitor LY 294002 decreased JNK stimulation induced by Gbeta gamma in a dose-dependent manner (Fig. 1B). Together these data point to an involvement of PI3K in the stimulation of JNK by G protein-coupled receptor.


View larger version (38K):
[in this window]
[in a new window]
 
Fig. 1.   Inhibition of JNK activation in COS-7 cells by wortmannin and LY 294002. A, effect of wortmannin on the stimulation of JNK induced by the m2 muscarinergic receptor and 1 mM carbachol (m2), Gbeta gamma , or anisomycin. Two days after transfection with expression plasmids of HA-JNK, and as indicated m2 receptor or Gbeta gamma cells were treated for 15 min with carbachol or anisomycin (10 µg/ml) in the presence or absence of 100 nM wortmannin. After lysis of the cells JNK kinase activity was assayed as described under "Experimental Procedures." B, dose-response effect of the PI3K inhibitor LY294002 on JNK stimulation induced by Gbeta gamma and anisomycin.

Trying to outline the PI3K species that induces Gbeta gamma -dependent JNK activation we expressed PI3Kgamma in COS-7 cells. As shown in Fig. 2A, PI3Kgamma moderately stimulated JNK activity. This effect could be significantly enhanced by coexpression of p101, a PI3Kgamma -binding protein recently discovered (12). p101 alone was unable to induce JNK stimulation. For a comparison Fig. 2A expresses the individual effects of p101, PI3Kgamma , and PI3Kgamma  + p101 on MAP kinase (ERK) activity. Interestingly p101 exhibited significantly lower potency to affect PI3Kgamma -dependent MAPK activity than JNK induced by PI3Kgamma . To examine possible autocrine reactions of the transfectants we analyzed the effects of conditioned media from COS-7 cells expressing PI3Kgamma and/or p101 on naive cells. Supernatants of the transfected cells did not induce any measurable stimulation of JNK activity in untreated cells, thus providing evidence for direct signaling from PI3Kgamma and p101 to JNK (data not shown). Fig. 2B demonstrates the dependence of JNK activation on the expression levels of p101 and PI3Kgamma . Thus optimal stimulation of JNK seems to depend on PI3Kgamma and p101.


View larger version (29K):
[in this window]
[in a new window]
 
Fig. 2.   JNK activation by PI3Kgamma in COS-7 cells. A, stimulation of JNK and MAPK activities by expression of PI3Kgamma and/or p101. COS-7 cells were transfected with HA-JNK or HA-MAPK and as indicated control vector or the expression plasmids of PI3Kgamma and/or p101. After 2 days cells were lysed, and JNK or MAPK activity was assayed. B, dose-response effect of PI3Kgamma and p101 on JNK activity. COS-7 cells were transfected with the control vector or indicated amounts of expression plasmids of PI3Kgamma and p101, and JNK activity was assayed after 2 days.

The activatory effect of PI3Kgamma on JNK could be completely inhibited by wortmannin suggesting an important role of the kinase activities of the PI3K (Fig. 3A). PI3Kgamma recently has been shown to exhibit a significant ability to catalyze autophosphorylation in addition to its lipid kinase activity (15). Both kinase activities depend on magnesium and can be inhibited by nanomolar concentrations of wortmannin. A recently described mutant of PI3Kgamma K799R, which does not express significant lipid kinase and protein kinase activities, was able to suppress the JNK stimulation induced by Gbeta gamma (Fig. 3B). Together with our previous report (10) these findings provide clear evidence that PI3Kgamma links both JNK and MAPK to G protein-coupled receptors. Involvement of PI3Kalpha , which recently has been shown to mediate signaling of platelet-derived growth factor receptor tyrosine kinase to JNK (16) seems improbable.


View larger version (29K):
[in this window]
[in a new window]
 
Fig. 3.   Requirement of PI3Kgamma catalytic activity for JNK activation. A, wortmannin blocks JNK activation induced by PI3Kgamma . COS-7 cells transfected with control vector or the expression plasmid of PI3Kgamma were treated with the indicated concentrations of wortmannin, and JNK activity was assayed. B, suppression of Gbeta gamma -mediated JNK activation by dominant negative mutant PI3Kgamma K799R. Pure vector or expression plasmids of Gbeta gamma or RacQL and as indicated the dominant negative mutant PI3Kgamma K799R were used for transfection. JNK activity was assayed after 48 h.

The recently described involvement of Ras and Rac in signal transduction from G protein-coupled receptors to JNK prompted us to investigate a possible role of these small GTPases in JNK stimulation induced by PI3Kgamma . As shown in Fig. 4A coexpression of dominant negative forms of Ras and Rac prevented activation of JNK by PI3Kgamma . In contrast coexpression of the negative mutants of two other small GTPases RhoA and Cdc42 did not affect the stimulation of JNK by PI3Kgamma . Therefore Ras and Rac1 seem to represent essential elements of the signaling path from PI3Kgamma to JNK. Expression of beta ARK as a binding protein for Gbeta gamma (9, 10) also suppressed JNK stimulation induced by PI3Kgamma (data not shown). This effect points to an essential role of Gbeta gamma as a link of G protein-coupled receptors to PI3Kgamma .


View larger version (47K):
[in this window]
[in a new window]
 
Fig. 4.   Involvement of Ras, Rac, and PAK in JNK activation by PI3Kgamma . A, effects of dominant negative mutants of Ras, Rac1, Cdc42, and RhoA on JNK activation induced by PI3Kgamma and p101. COS-7 cells were transfected with control vector or expression plasmids of PI3Kgamma and p101 and with dominant negative mutants of Ras, Rac1, Cdc42, and RhoA, and JNK was assayed after 2 days. B, effect of dominant negative PAK on JNK activation by PI3Kgamma . Stimulation of JNK was induced by expression of Gbeta gamma , PI3Kgamma  + p101, RacQL or incubation with anisomycin (10 µg/ml, 15 min), and the effect of dominant negative PAK(N) expression on JNK activity was assayed. Levels of JNK expression were equal in every assay (data not shown).

We next explored a possible involvement of protein kinase PAK in downstream signaling from PI3Kgamma to JNK. The coexpression of a dominant negative mutant of this protein kinase also induced a partial suppression of JNK stimulation by Gbeta gamma , PI3Kgamma , and a constitutively active mutant of Rac (Fig. 4B). Thus signaling from G protein-coupled receptor to JNK appears to require Gbeta gamma , PI3Kgamma , Ras, Rac, and PAK.

Nevertheless the sequence of events connecting PI3Kgamma and JNK remains unclear. A PI3Kgamma effect on Ras has been proposed in our previous report on ERK activation by PI3Kgamma (10). In this paper we provide evidences that Ras could be activated by PI3Kgamma via a Src-type tyrosine kinase, the adapter proteins Shc and Grb2, and the guanine nucleotide exchange factor Sos. Stimulated in this way Ras could act as a dissociation point for signals from PI3Kgamma to ERK and JNK. Such a bifurcating function of Ras as a regulator of the Raf-ERK path and signal transduction to Rac, PAK, and JNK has been proposed (6).

Despite the attractiveness of this model some experimental data point to a more complex relation of the signaling proteins involved. Thus the differential effects of p101 on the PI3Kgamma -dependent stimulation of ERK and JNK cannot be explained by simple sequential signal transduction from PI3Kgamma via the lipid kinase product PIP3 to Ras and subsequent stimulation of JNK and ERK paths. One possible explanation for the distinct effects of PI3Kgamma and its ligands on the MAPK cascades could be the involvement of signaling activities of the enzyme in addition to PIP3 production. Wortmannin-sensitive protein kinase activity of PI3Kgamma has been reported (15). If Gbeta gamma and p101 produce divergent effects on the lipid kinase and protein kinase activities of PI3Kgamma and if both activities are important for signal transduction different downstream events could be expected. The individual signaling functions of PI3Kgamma lipid kinase and protein kinase activities are currently under investigation. The effects of PI3Kgamma on different MAPK cascades clearly represent another example for the complex interrelations of these intracellular signaling proteins.

    ACKNOWLEDGEMENTS

We are very grateful to Drs. Len Stephens and Phill Hawkins for providing us with the pcDNA3-p101 construct.

    FOOTNOTES

* This work was supported by Deutsche Forschungsgemeinschaft Grants SFB 197.The costs of publication of this article were defrayed in part by the payment of page charges. The article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.

§ To whom correspondence should be addressed: Max-Planck Research Unit "Molecular Cell Biology," Drackendorfer Straße 1, D 07747 Jena, Germany. Tel.: 49-3641-304-460; Fax: 49-3641-304-462; E-mail: i5rewe{at}rz.uni-jena.de.

1 The abbreviations used are: MAPK, mitogen-activated protein kinase; PI3K, phosphoinositide 3-kinase; ERK, extracellular signal-regulated kinase; JNK (or SAPK), c-Jun NH2-terminal kinase (or stress-activated protein kinase); PIP3, phosphatidylinositol 3,4,5-trisphosphate; HA, hemagglutinin; MOPS, 4-morpholinepropanesulfonic acid.

    REFERENCES
Top
Abstract
Introduction
Procedures
Results & Discussion
References

  1. Cano, E., and Mahadevan, L. C. (1995) Trends Biochem. Sci. 20, 117-122[CrossRef][Medline] [Order article via Infotrieve]
  2. Davis, R. J. (1993) J. Biol. Chem. 270, 14553-14556
  3. Kyriakis, J., Banerjee, P., Nikolakaki, E., Dai, T., Rubie, E., Ahmad, M., Avruch, J., and Woodgett, J. (1994) Nature 369, 156-160[CrossRef][Medline] [Order article via Infotrieve]
  4. Coso, O. A., Chiariello, M., Kalinec, G., Kyriakis, J. M., Woodgett, J., Gutkind, J. S. (1995) J. Biol. Chem. 270, 5620-5624[Abstract/Free Full Text]
  5. Ridley, A. J. (1996) Curr. Biol. 6, 1256-1264[CrossRef][Medline] [Order article via Infotrieve]
  6. Bagrodia, S., Derijard, B., Davis, R. J., Cerione, R. A. (1995) J. Biol. Chem. 270, 27995-27998[Abstract/Free Full Text]
  7. Coso, O. A., Teramoto, H., Simonds, W. F., Gutkind, J. S. (1996) J. Biol. Chem. 271, 3963-3966[Abstract/Free Full Text]
  8. Minden, A., Lin, A., Claret, F.-X., Abo, A., and Karin, M. (1995) Cell 81, 1147-1157[CrossRef][Medline] [Order article via Infotrieve]
  9. Coso, O. A., Chiariello, M., Yu, J.-C., Crespo, P., Xu, N., Miki, T., and Gutkind, J. S. (1995) Cell 81, 1137-1146[CrossRef][Medline] [Order article via Infotrieve]
  10. Lopez-Ilasaca, M., Crespo, P., Pellici, P. G., Gutkind, S., Wetzker, R. (1997) Science 275, 394-397[Abstract/Free Full Text]
  11. Crespo, P., Xu, N., Simonds, W. F., Gutkind, J. S. (1994) Nature 369, 418-420[CrossRef][Medline] [Order article via Infotrieve]
  12. Stephens, L. R., Eguinoa, A., Erdjument-Bromage, H., Lui, M., Cooke, F., Coadwell, J., Smrcka, A. S., Thelen, M., Cadwallader, K., Tempst, P., Hawkins, P. T. (1997) Cell 89, 105-114[CrossRef][Medline] [Order article via Infotrieve]
  13. Takeya, T., and Hanafusa, H. (1983) Cell 32, 881-889[CrossRef][Medline] [Order article via Infotrieve]
  14. Teramoto, H., Crespo, P., Coso, O. A., Igishi, T., Xu, N., Gutkind, J. S. (1996) J. Biol. Chem. 271, 25731-25734[Abstract/Free Full Text]
  15. Stoyanova, S., Bulgarelli-Leva, G., Kirsch, C., Hanck, T., Klinger, R., Wetzker, R., and Wymann, M. P. (1997) Biochem. J. 324, 489-495
  16. Lopez-Ilasaca, M., Li, W., Uren, A., Yu, J., Kazlauskas, A., Gutkind, J. S., Heidaran, M. A. (1997) Biochem. Biophys. Res. Commun. 232, 273-277[CrossRef][Medline] [Order article via Infotrieve]


Copyright © 1998 by The American Society for Biochemistry and Molecular Biology, Inc.



This article has been cited by other articles:


Home page
Mol. Pharmacol.Home page
A. S. L. Chan and Y. H. Wong
Gq-Mediated Activation of c-Jun N-Terminal Kinase by the Gastrin-Releasing Peptide-Preferring Bombesin Receptor Is Inhibited upon Costimulation of the Gs-Coupled Dopamine D1 Receptor in COS-7 Cells
Mol. Pharmacol., November 1, 2005; 68(5): 1354 - 1364.
[Abstract] [Full Text] [PDF]


Home page
Mol. Pharmacol.Home page
H. Cheng, J. A. Grodnitzky, S. Yibchok-anun, J. Ding, and W. H. Hsu
Somatostatin Increases Phospholipase D Activity and Phosphatidylinositol 4,5-bisphosphate Synthesis in Clonal {beta} Cells HIT-T15
Mol. Pharmacol., June 1, 2005; 67(6): 2162 - 2172.
[Abstract] [Full Text] [PDF]


Home page
BloodHome page
S. Montaner, A. Sodhi, J.-M. Servitja, A. K. Ramsdell, A. Barac, E. T. Sawai, and J. S. Gutkind
The small GTPase Rac1 links the Kaposi sarcoma-associated herpesvirus vGPCR to cytokine secretion and paracrine neoplasia
Blood, November 1, 2004; 104(9): 2903 - 2911.
[Abstract] [Full Text] [PDF]


Home page
Mol. Interv.Home page
M. B. Jones, D. P. Siderovski, and S. B. Hooks
The G{beta}{gamma} DIMER as a NOVEL SOURCE of SELECTIVITY in G-Protein Signaling: GGL-ing AT CONVENTION
Mol. Interv., August 1, 2004; 4(4): 200 - 214.
[Abstract] [Full Text] [PDF]


Home page
J. Pharmacol. Exp. Ther.Home page
A. Y. F. Kam, A. S. L. Chan, and Y. H. Wong
{kappa}-Opioid Receptor Signals through Src and Focal Adhesion Kinase to Stimulate c-Jun N-Terminal Kinases in Transfected COS-7 Cells and Human Monocytic THP-1 Cells
J. Pharmacol. Exp. Ther., July 1, 2004; 310(1): 301 - 310.
[Abstract] [Full Text] [PDF]


Home page
J. Leukoc. Biol.Home page
G. M. Fuhler, K. A. Cadwallader, G. J. Knol, E. R. Chilvers, A. L. Drayer, and E. Vellenga
Disturbed granulocyte macrophage-colony stimulating factor priming of phosphatidylinositol 3,4,5-trisphosphate accumulation and Rac activation in fMLP-stimulated neutrophils from patients with myelodysplasia
J. Leukoc. Biol., July 1, 2004; 76(1): 254 - 262.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
S. Liu, R. T. Premont, C. D. Kontos, J. Huang, and D. C. Rockey
Endothelin-1 Activates Endothelial Cell Nitric-oxide Synthase via Heterotrimeric G-protein {beta}{gamma} Subunit Signaling to Protein Kinase B/Akt
J. Biol. Chem., December 12, 2003; 278(50): 49929 - 49935.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
S. Kraus, O. Benard, Z. Naor, and R. Seger
c-Src Is Activated by the Epidermal Growth Factor Receptor in a Pathway That Mediates JNK and ERK Activation by Gonadotropin-releasing Hormone in COS7 Cells
J. Biol. Chem., August 29, 2003; 278(35): 32618 - 32630.
[Abstract] [Full Text] [PDF]


Home page
J. Cell Sci.Home page
K. E. Bruckener, A. el Baya, H.-J. Galla, and M. A. Schmidt
Permeabilization in a cerebral endothelial barrier model by pertussis toxin involves the PKC effector pathway and is abolished by elevated levels of cAMP
J. Cell Sci., May 1, 2003; 116(9): 1837 - 1846.
[Abstract] [Full Text] [PDF]


Home page
J. Cell Biol.Home page
C. Brock, M. Schaefer, H. P. Reusch, C. Czupalla, M. Michalke, K. Spicher, G. Schultz, and B. Nurnberg
Roles of G{beta}{gamma} in membrane recruitment and activation of p110{gamma}/p101 phosphoinositide 3-kinase {gamma}
J. Cell Biol., January 2, 2003; 160(1): 89 - 99.
[Abstract] [Full Text] [PDF]


Home page
Cell Growth Differ.Home page
S. Dehez, C. Bierkamp, A. Kowalski-Chauvel, L. Daulhac, C. Escrieut, C. Susini, L. Pradayrol, D. Fourmy, and C. Seva
c-Jun NH2-terminal Kinase Pathway in Growth-promoting Effect of the G Protein-coupled Receptor Cholecystokinin B Receptor: A Protein Kinase C/Src-dependent-Mechanism
Cell Growth Differ., August 1, 2002; 13(8): 375 - 385.
[Abstract] [Full Text] [PDF]


Home page
Mol. Pharmacol.Home page
S. M. Miggin and B. T. Kinsella
Regulation of Extracellular Signal-Regulated Kinase Cascades by alpha - and beta -Isoforms of the Human Thromboxane A2 Receptor
Mol. Pharmacol., April 1, 2002; 61(4): 817 - 831.
[Abstract] [Full Text] [PDF]


Home page
Circ. Res.Home page
S. F. Steinberg
PI3King the L-Type Calcium Channel Activation Mechanism
Circ. Res., October 12, 2001; 89(8): 641 - 644.
[Full Text] [PDF]


Home page
Mol. Pharmacol.Home page
M. Yoshizumi, K. Tsuchiya, K. Kirima, M. Kyaw, Y. Suzaki, and T. Tamaki
Quercetin Inhibits Shc- and Phosphatidylinositol 3-Kinase-Mediated c-Jun N-Terminal Kinase Activation by Angiotensin II in Cultured Rat Aortic Smooth Muscle Cells
Mol. Pharmacol., October 1, 2001; 60(4): 656 - 665.
[Abstract] [Full Text] [PDF]


Home page
Mol. Pharmacol.Home page
S. Faivre, K. Regnauld, E. Bruyneel, Q.-D. Nguyen, M. Mareel, S. Emami, and C. Gespach
Suppression of Cellular Invasion by Activated G-Protein Subunits Galpha o, Galpha i1, Galpha i2, and Galpha i3 and Sequestration of Gbeta gamma
Mol. Pharmacol., August 1, 2001; 60(2): 363 - 372.
[Abstract] [Full Text] [PDF]


Home page
EndocrinologyHome page
K. Morino, H. Maegawa, T. Fujita, N. Takahara, K. Egawa, A. Kashiwagi, and R. Kikkawa
Insulin-Induced c-Jun N-Terminal Kinase Activation Is Negatively Regulated by Protein Kinase C {{delta}}
Endocrinology, June 1, 2001; 142(6): 2669 - 2676.
[Abstract] [Full Text] [PDF]


Home page
Mol. Pharmacol.Home page
S.-J. Eom, E. Y. Kim, J. E. Lee, H. J. Kang, J. Shim, S. U. Kim, B. J. Gwag, and E.-J. Choi
Zn2+ Induces Stimulation of the c-Jun N-Terminal Kinase Signaling Pathway through Phosphoinositide 3-Kinase
Mol. Pharmacol., April 16, 2001; 59(5): 981 - 986.
[Abstract] [Full Text]


Home page
CirculationHome page
G. Esposito, S. V. N. Prasad, A. Rapacciuolo, L. Mao, W. J. Koch, and H. A. Rockman
Cardiac Overexpression of a Gq Inhibitor Blocks Induction of Extracellular Signal-Regulated Kinase and c-Jun NH2-Terminal Kinase Activity in In Vivo Pressure Overload
Circulation, March 13, 2001; 103(10): 1453 - 1458.
[Abstract] [Full Text] [PDF]


Home page
J. Cell Biol.Home page
C. Bony, S. Roche, U. Shuichi, T. Sasaki, M. A. Crackower, J. Penninger, H. Mano, and M. Puceat
A Specific Role of Phosphatidylinositol 3-Kinase {gamma}: A Regulation of Autonomic Ca2+ Oscillations in Cardiac Cells
J. Cell Biol., February 20, 2001; 152(4): 717 - 728.
[Abstract] [Full Text] [PDF]


Home page
J. Pharmacol. Exp. Ther.Home page
A. S. L. Chan and Y. H. Wong
Regulation of c-Jun N-Terminal Kinase by the ORL1 Receptor through Multiple G Proteins
J. Pharmacol. Exp. Ther., December 1, 2000; 295(3): 1094 - 1100.
[Abstract] [Full Text]


Home page
BloodHome page
K. J. Procyk, M. R. Rippo, R. Testi, F. Hofmann, P. J. Parker, and M. Baccarini
Lipopolysaccharide induces Jun N-terminal kinase activation in macrophages by a novel Cdc42/Rac-independent pathway involving sequential activation of protein kinase C zeta and phosphatidylcholine-dependent phospholipase C
Blood, October 1, 2000; 96(7): 2592 - 2598.
[Abstract] [Full Text] [PDF]


Home page
Mol. Cell. Biol.Home page
L. A. Sellers, F. Alderton, A. M. Carruthers, M. Schindler, and P. P. A. Humphrey
Receptor Isoforms Mediate Opposing Proliferative Effects through Gbeta gamma -Activated p38 or Akt Pathways
Mol. Cell. Biol., August 15, 2000; 20(16): 5974 - 5985.
[Abstract] [Full Text]


Home page
J. Biol. Chem.Home page
U. Maier, A. Babich, N. Macrez, D. Leopoldt, P. Gierschik, D. Illenberger, and B. Nurnberg
Gbeta 5gamma 2 Is a Highly Selective Activator of Phospholipid-dependent Enzymes
J. Biol. Chem., April 28, 2000; 275(18): 13746 - 13754.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
C. Murga, S. Fukuhara, and J. S. Gutkind
A Novel Role for Phosphatidylinositol 3-Kinase beta in Signaling from G Protein-coupled Receptors to Akt
J. Biol. Chem., April 14, 2000; 275(16): 12069 - 12073.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
J. Yamauchi, T. Kawano, M. Nagao, Y. Kaziro, and H. Itoh
Gi-dependent Activation of c-Jun N-terminal Kinase in Human Embryonal Kidney 293 Cells
J. Biol. Chem., March 10, 2000; 275(11): 7633 - 7640.
[Abstract] [Full Text] [PDF]


Home page
Mol. Cell. Biol.Home page
M. H. Ghahremani, C. Forget, and P. R. Albert
Distinct Roles for Galpha i2 and Gbeta gamma in Signaling to DNA Synthesis and Galpha i3 in Cellular Transformation by Dopamine D2S Receptor Activation in BALB/c 3T3 Cells
Mol. Cell. Biol., March 1, 2000; 20(5): 1497 - 1506.
[Abstract] [Full Text]


Home page
J. Biol. Chem.Home page
M. Kiyono, Y. Kaziro, and T. Satoh
Induction of Rac-Guanine Nucleotide Exchange Activity of Ras-GRF1/CDC25Mm following Phosphorylation by the Nonreceptor Tyrosine Kinase Src
J. Biol. Chem., February 25, 2000; 275(8): 5441 - 5446.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
S. V. Naga Prasad, G. Esposito, L. Mao, W. J. Koch, and H. A. Rockman
Gbeta gamma -dependent Phosphoinositide 3-Kinase Activation in Hearts with in Vivo Pressure Overload Hypertrophy
J. Biol. Chem., February 18, 2000; 275(7): 4693 - 4698.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
K. Fukunaga, T. Noguchi, H. Takeda, T. Matozaki, Y. Hayashi, H. Itoh, and M. Kasuga
Requirement for Protein-tyrosine Phosphatase SHP-2 in Insulin-induced Activation of c-Jun NH2-terminal Kinase
J. Biol. Chem., February 18, 2000; 275(7): 5208 - 5213.
[Abstract] [Full Text] [PDF]


Home page
J. Neurosci.Home page
K. Rosenblum, M. Futter, M. Jones, E. C. Hulme, and T. V. P. Bliss
ERKI/II Regulation by the Muscarinic Acetylcholine Receptors in Neurons
J. Neurosci., February 1, 2000; 20(3): 977 - 985.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
H. Ueda, H. Itoh, J. Yamauchi, R. Morishita, Y. Kaziro, K. Kato, and T. Asano
G Protein beta gamma Subunits Induce Stress Fiber Formation and Focal Adhesion Assembly in a Rho-dependent Manner in HeLa Cells
J. Biol. Chem., January 21, 2000; 275(3): 2098 - 2102.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
M. Laffargue, P. Raynal, A. Yart, C. Peres, R. Wetzker, S. Roche, B. Payrastre, and H. Chap
An Epidermal Growth Factor Receptor/Gab1 Signaling Pathway Is Required for Activation of Phosphoinositide 3-Kinase by Lysophosphatidic Acid
J. Biol. Chem., November 12, 1999; 274(46): 32835 - 32841.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
K. J. Procyk, M. R. Rippo, R. Testi, F. Hoffmann, P. J. Parker, and M. Baccarini
Distinct Mechanisms Target Stress and Extracellular Signal-Activated Kinase 1 and Jun N-Terminal Kinase During Infection of Macrophages with Salmonella
J. Immunol., November 1, 1999; 163(9): 4924 - 4930.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
D. R. Jones, A. Gonzalez-Garcia, E. Diez, C. Martinez-A., A. C. Carrera, and I. Merida
The Identification of Phosphatidylinositol 3,5-bisphosphate in T-lymphocytes and Its Regulation by Interleukin-2
J. Biol. Chem., June 25, 1999; 274(26): 18407 - 18413.
[Abstract] [Full Text] [PDF]